Hormone replacement unhealthy

The move to "medicalize menopause" began in the '60s with the publication of "Forever Feminine", a book subsidized by Wyeth and promoting hormone replacement therapy (HRT) as a virtual fountain of youth for the "dull and unattractive" aging woman, writes Jocelyn Clark in the August 16 issue of the British Medical Journal. Wyeth reaped the benefits; the company now holds 70 per cent of the HRT market around the world.

But now evidence has emerged that shows long-term use of HRT increases a woman's risk of having blood clots, a stroke, a heart attack, breast cancer and dementia. And HRT is now shown to have no quality of life benefits.

The pharmaceutical industry is pushing its PR machine to new heights to combat the latest threat to its multi-billion dollar cash cow. Their PR firms have been busy getting testimonials from celebrities and non-profit organizations who benefit from the the industry's largesse. The goal is to downplay the health risks and to convince women they can have better health, sex, careers and relationships if they use HRT.

'Tain't so.